$DOW 2Q15 PR: Net Sales were $12,910MM, down 13% vs. $14,917MM in 2Q14, with declines driven primarily by currency & lower oil price. Sequentially, sales grew 4% with gains across all geographic areas & sales increases were led by Greater China up 14% and US up 6%. Net Income available for stockholders were $1,135MM vs. $882MM in 2Q14.
$FTR reorganized its business structure with the creation of new consumer and commercial business. The company said that the previous structures were more regionally focused and it had seven regions structure before the reorganization.
$PCLN believes that over the next decade China will continue to be
one of the largest opportunities for travel growth in terms of increasing market
share for the company. $PCLN also sees opportunities to increase domestic market
share in the US.
$PRGO said that in the Consumer Healthcare business, it has been seeing certain pricing pressure. Therefore, across categories $PRGO competes in, it has competitive pricing. The company expects pricing pressure to continue in different segments going forward. But given the growth in new products, $PRGO expects to overcome the pricing challenges.